Nanotherapeutics Inc. is an emerging specialty pharmaceutical company with expertise in the early-stage development of pharmaceuticals. The company employs several platform technologies to manipulate and enhance the properties of drugs. These technologies can be employed with new chemical entities or with generic drugs and can be used with the spectrum of existing drug types ranging from small synthetic molecules to large recombinant macromolecules.
Significant advances have been made in the area of nanometer-scale particle delivery and Nanotherapeutics has created three proprietary drug delivery technologies: NanoQUAD™, NanoDRY™, and NanoCOAT™. These specialized proprietary techniques can improve the release rate and enhance both the rate and extent of drug uptake, thus increasing bioavailability. The consequences of these changes include more consistent drug therapy with potentially reduced dose and dose frequency requirements and fewer side effects.
Advanced Materials Used in Military Technology
Nanotherapeutics Announces Conclusion of Type C Meeting with the US FDA
Nanotherapeutics Breaks Ground on Advanced Development and Manufacturing Center in Alachua, Florida
Nanotherapeutics Secures Funds to Conduct Clinical Trial on NanoDOX Hydrogel
Nanotherapeutics Files Investigational New Drug Application for NanoDTPA Capsule
Nanotherapeutics Acquires in Bankruptcy Proceedings Two Late Stage Clinical Programs
Nanotherapeutics Awarded Multi-Million Contract from National Institute of Allergy and Infectious Diseases
Nano Drug Company Submits Investigational New Drug Application with FDA for NanoBUP
Professor Jacek Jasienak
In this interview, we discuss a nanoparticle ink used to produce low-cost printable perovskite solar cells, helping to catalyze the technology transition toward commercial viable perovskite-based devices.
Ping Wang, Ph.D.
We speak with researchers behind the latest advancement in graphene hBN research that could boost the development of next-generation electronic and quantum devices.
Dr. Laurene Tetard
AZoNano speaks with Dr. Laurene Tetard from the University of Central Florida about her upcoming research into the development of nanotechnology that can detect animal-borne diseases. The hope is that such technology can be used to help rapidly control infected mosquito populations to protect public
The Filmetrics R54 advanced sheet resistance mapping tool for semiconductor and compound semiconductor wafers.
This product profile describes the latest nano-particle analyzer "thesis particle size analyzer" and its key
The Filmetrics F40 turns your benchtop microscope into an instrument for measuring thickness and refractive index.